# FDA Inspection 551865 - Robert Boissoneault Oncology Institute - December 12, 2008

Source: https://www.keypedia.com/records/fda_inspections/robert-boissoneault-oncology-institute/38b283d6-a1ca-4dc7-bd8d-33bbd4a5b922
Source feed: FDA_Inspections

> FDA Inspection 551865 for Robert Boissoneault Oncology Institute on December 12, 2008. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 551865
- Company Name: Robert Boissoneault Oncology Institute
- Inspection Date: 2008-12-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 719383 - 2011-04-12](https://www.keypedia.com/records/fda_inspections/robert-boissoneault-oncology-institute/a27709fb-1680-411f-9e08-b827df89fe18)

Company: https://www.keypedia.com/companies/robert-boissoneault-oncology-institute/257fb5d2-ec8a-4f4c-9d95-afb778a1f75a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
